Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

STEMIN- and YAP5SA-induced exosomes prevent cardiomyocyte apoptosis.

iScience·2026
Same author

Distinct populations of vascular smooth muscle and sinoatrial progenitors are localized adjacent to pro-epicardium.

Cell reports·2025
Same author

Tunneling nanotube-like structures regulate distant cellular interactions during heart formation.

Science (New York, N.Y.)·2025
Same author

STEMIN and YAP5SA, the future of heart repair?

Experimental biology and medicine (Maywood, N.J.)·2024
Same author

β1 integrins regulate cellular behaviour and cardiomyocyte organization during ventricular wall formation.

Cardiovascular research·2024
Same author

A Small Molecule That In Vitro Neutralizes Infection of SARS-CoV-2 and Its Most Infectious Variants, Delta, and Omicron.

Biomedicines·2023

Video Experimental Relacionado

Updated: Jul 11, 2026

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart
08:13

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart

Published on: September 13, 2011

El CAMTA en la hipertrofia cardíaca.

Robert J Schwartz1, Michael D Schneider

  • 1The Institute of Biosciences and Technology, The Texas A&M University System Health Science Center, Houston, TX 77030, USA. rschwartz@ibt.tamhsc.edu

Cell
|May 9, 2006
PubMed
Resumen

El activador de transcripción de unión a la calmodulina 2 (CAMTA2) es esencial para la hipertrofia cardíaca. Activa los genes involucrados en esta condición al interactuar con Nkx2-5 después de disociarse de la histona deacetilasa 5.

Área de la Ciencia:

  • Biología molecular La biología molecular.
  • Investigaciones cardiovasculares en la investigación cardiovascular.
  • Regulación genética La regulación genética.

Sus antecedentes:

  • La hipertrofia cardíaca es una condición cardiovascular significativa.
  • Comprender los mecanismos moleculares que impulsan la hipertrofia cardíaca es crucial para desarrollar tratamientos efectivos.

Objetivo del estudio:

  • Para investigar el papel del activador de transcripción de unión a la calmodulina 2 (CAMTA2) en la hipertrofia cardíaca.
  • Para dilucidar el mecanismo por el cual CAMTA2 regula los genes asociados con la hipertrofia cardíaca.

Principales métodos:

  • El estudio utilizó técnicas moleculares y genéticas para evaluar la función de CAMTA2.
  • Se investigó la interacción entre CAMTA2, histona desacetilasa 5 y Nkx2-5.5.

Más Videos Relacionados

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

Videos de Experimentos Relacionados

Last Updated: Jul 11, 2026

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart
08:13

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart

Published on: September 13, 2011

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

Principales resultados:

  • CAMTA2 fue identificado como un coactivador de transcripción indispensable para la hipertrofia cardíaca.
  • La activación de CAMTA2 implica la disociación de la histona desacetilasa clase II 5.
  • CAMTA2 promueve la transcripción de genes relacionados con la hipertrofia cardíaca a través de la interacción Nkx2-5.

Conclusiones:

  • CAMTA2 juega un papel crítico en el desarrollo de la hipertrofia cardíaca.
  • Dirigirse a la vía CAMTA2 puede ofrecer una estrategia terapéutica para la hipertrofia cardíaca.